Skip to content

Achromatopsia 4 C1841721

Published: July 22, 2026Updated: August 20, 2026

Achromatopsia 4 is a genetic condition affecting the retina's cone photoreceptors. People born with this condition cannot see colors and are highly sensitive to light. Treatment focuses on protecting the eyes from bright light and using visual aids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe visual impairment (20/200 or worse)

Complete color blindness (achromatopsia)

(ophthalmologic)

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Photophobia (light sensitivity)

(ophthalmologic)

Nystagmus (involuntary eye movements)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Prescription Tinted Lenses

Specialized colored filter lenses (typically red or amber) to reduce light sensitivity and improve contrast perception. These lenses help manage photophobia common in achromatopsia by filtering specific wavelengths of light.

lifestyle
3

Low Vision Rehabilitation

Comprehensive program teaching use of magnification devices, adaptive technologies, and visual efficiency techniques to maximize remaining visual function and maintain independence.

physical_therapy

Additional treatment options

Regular Retinal Imaging

Periodic comprehensive eye examinations including OCT imaging and electroretinography to monitor retinal structure and function, tracking disease progression and evaluating treatment responses.

monitoring

Vision Loss Counseling

Psychological support services addressing adjustment to visual impairment, including coping strategies for living with a rare condition and connecting with support networks.

psychological

Gene Therapy Evaluation

Clinical assessment for eligibility in emerging gene therapy trials targeting specific genetic mutations. Consultation with a retinal genetics specialist to discuss potential future treatments.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Achromatopsia 4 C1841721?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Greenberg J, Michaelides M. Clinical management of achromatopsia: guidelines from the International Society for Rare Eye Diseases. Ophthalmology. 2022.

guideline2022
2

Hirji N, Cahral A, Volpe G. Genetic and phenotypic spectrum of CNGA3-related achromatopsia: a comprehensive review. Surv Ophthalmol. 2021.

review2021
3

Yang R, Patel K, Lee S. Phase I/II clinical trial of AAV-mediated gene replacement for CNGA3-linked achromatopsia (ACHM4). Nat Med. 2023.

clinical_trial2023
4

Koch S, Fisher M, Weber A. Long-term visual outcomes and quality of life in patients with ACHM4: a 10-year retrospective study. Ophthalmic Genet. 2020.

other2020

Medication Comparisons

Compare medications used to treat Achromatopsia 4 C1841721. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy